BSEBeryl Drugs LtdMediumNeutral
Announced Tue, 12 May · 17:21 IST

VOTING RESULTS OF EGM HELD ON 11.05.2026

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹20.50
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0+3.2-2.0-2.0-3.4+4.1+14.6+7.2
Up moveDown movePending
AI summary

Beryl Drugs Ltd held an Extra-Ordinary General Meeting on 11 May 2026 where three ordinary resolutions were passed unanimously. The resolutions included regularization of Mr. Shailendra Pathak as Whole Time Director, appointment of Mrs. Neha Sarda as Non-Executive Independent Director, and approval of a material related party transaction with M/S. Aminova Infusions P. Ltd. The meeting was attended by 4 promoter and 42 public shareholders. Total votes polled were 1,683,633 out of 5,071,700 outstanding shares (33.19% turnout), with 100% votes in favor for all three resolutions.

Likely market impact

All resolutions passed with unanimous shareholder support, indicating strong backing for the new director appointments and the related party transaction with Aminova Infusions P. Ltd. This suggests confidence in management decisions.